Ehime University and Sumitomo Pharma Launch Joint Research on Multi-Stage Malaria Vaccine Candidate Supported by GHIT Fund
stellanews.life/technology/8...
#Malaria #Vaccine #SumitomoPharma #EhimeUniversity #GHITFund #GlobalHealth
🎉 GHIT Fund is now a GloPID-R member!
GHIT mobilizes Japanese industry, academia & global partners to develop innovative drugs, vaccines & diagnostics for neglected infectious diseases in LICs & LMICs.
👉🏻 Our members at glance: www.glopid-r.org/members/
#GlobalHealth #GHITFund
📢 #GHITFund Call for Applications: Screening Platform
🧪 Support the identification of novel compounds for malaria, tuberculosis, and selected NTDs
🔓 Access Japanese compound libraries and screening technologies
⏰ Submission deadline: Jan 9, 2026
🔗 shorturl.at/aBw3c
📢 Our latest #newsletter is out! 📷 Message from the GloPID-R Board and latest from #PandemicPACT 📷 Updates from Members #ANRS #GlobalHealthEDCTP3 #IDRC #GHITFund
📷 Read & subscribe: glopid-r.org/newsletter/n...
#GlobalHealth #PandemicPreparedness #GloPIDR
🚨 #GHITFund Call for Proposals!
Apply now to develop new drugs, vaccines & diagnostics for infectious diseases in the developing world 🌍
📅 Deadline: July 9, 2025, 10:00 am JST
🔗 shorturl.at/eMNEP
We were pleased to join the GHIT R&D Forum 2024 in Tokyo!
Our Discovery Director, Charles Mowbray, highlighted the key role of Japanese researchers in our #R&D portfolio. With #GHITFund support, Japan fosters a unique environment to tackle #NeglectedDiseases through innovative solutions.
